Background Neuroimaging studies help us better understand the pathophysiology and
symptoms of Parkinson's disease (PD). In several of these studies, diffusion tensor imaging …

Cognitive decline is now recognized as a common nonmotor symptom of Parkinson's
disease, and it has been the subject of increasing research in recent decades. Cognitive …

Reactive oxygen species (ROS) are normally produced during cell metabolism, there is
strong evidence to suggest that ROS produced in excess impair the cell and may be …

Parkinson's disease (PD) is a neurodegenerative disorder that predominantly affects the
motor system. Diffusion magnetic resonance imaging (MRI) has demonstrated deficits in …

Magnetic resonance imaging (MRI) has the potential to serve as a biomarker for Parkinson's
disease (PD). However, the type or types of biomarker it could provide remain to be …

Higher plasma cholesterol levels are associated with lower Parkinson's disease (PD) risk.
Apolipoprotein A-1 (ApoA-1) is a surface marker of brain HDL-like particles associated with …

In vivo imaging that reliably captures the impact of the spreading pathology of Parkinson's
disease (PD), including its impact on both white and gray matter, remains elusive. In this …

Parkinson's disease (PD) is a neurodegenerative disorder that predominantly affects the
motor system. Diffusion magnetic resonance imaging (MRI) has demonstrated deficits in …

Motor signs and symptoms of Parkinson's disease (PD) are a result of the degeneration of
large parts of the substantia nigra (SN). PD also involves the degeneration of multiple …

In 1999, Jankovic et al., first described RET in a small sample of patients affected by
Parkinson's Disease (PD). The authors observed that PD patients with rest tremor may show …